Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Hematopoietic Stem Cell Transplantation Market Size, Value And Growth Trajectory Through 2030
The hematopoietic stem cell transplantation market has experienced rapid expansion in its size over recent years. This market is anticipated to increase from $5.1 billion in 2025 to $5.64 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.6%. The historical growth can be attributed to several factors, including the increasing prevalence of hematologic disorders, the expansion of transplant centers, improved donor matching techniques, the rising use of autologous transplants, and advancements in supportive care protocols.
The hematopoietic stem cell transplantation market is projected for significant expansion in the coming years. This market is anticipated to reach a value of $8.57 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.0%. Factors contributing to this growth during the forecast period include the increasing uptake of gene-modified stem cell therapies, greater investments in transplant infrastructure, the broadening scope of allogeneic transplant procedures, a rising emphasis on personalized transplant approaches, and improved survival rates following transplantation. Key trends expected within the forecast period encompass the wider adoption of peripheral blood stem cell transplants, the increasing utilization of cord blood transplantation, the expanding incorporation of precision conditioning regimens, the enlargement of donor registry networks, and a heightened focus on monitoring after transplantation.
Get A Free Sample Report With In-Depth Market Insights:
Hematopoietic Stem Cell Transplantation Market Development Factors: What’s Supporting Demand?
An anticipated rise in the occurrence of blood cancer is poised to drive the expansion of the hematopoietic stem cell transplantation market. Blood cancers are defined as a category of malignant conditions affecting the creation and functioning of blood cells. The primary categories of blood cancer include leukemia, lymphoma, and myeloma. Hematopoietic stem cell transplantation is a common treatment for blood cancer, functioning by replacing stem cells and bone marrow cells that have been destroyed by the malignancy. Subsequently, these newly introduced stem cells migrate to the bone marrow and commence the generation of new blood cells. Consequently, these aspects enhance the hematopoietic stem cell transplantation market. For instance, in September 2025, as reported by Cancer Research UK, a UK-based charity, the United Kingdom’s leukemia incidence rate is approximated at 17.9 cases per 100,000 people per year from 2024 to 2026, with a projected reduction of 3% to approximately 17.4 per 100,000 by 2038 to 2040. Hence, the heightened incidence of blood cancer fuels the hematopoietic stem cell transplantation market.
Hematopoietic Stem Cell Transplantation Market Segment Outlook: Which Categories Are Growing Fastest?
The hematopoietic stem cell transplantation market covered in this report is segmented –
1) By Type: Allogeneic, Autologous
2) By Indication: Leukemia, Lymphatic Disorder, Myeloma, Other Non-Malignant Disorders
3) By Application: Bone Marrow Transplant, Peripheral Blood Stem Cell Transplant, Cord Blood Transplant
4) By End User: Hospital Pharmacy, Specialty Clinics
Subsegments:
1) By Allogeneic: Matched Related Donor Transplantation, Matched Unrelated Donor Transplantation, Cord Blood Transplantation
2) By Autologous: Peripheral Blood Stem Cell Transplantation, Bone Marrow Stem Cell Transplantation
Hematopoietic Stem Cell Transplantation Market Trends Powering Strategic Industry Growth
Major companies in hematopoietic stem cell transplantation are concentrating on developing innovations such as digital tools to streamline patient management, enhance donor matching processes, and provide real-time data analytics for improved decision-making. Digital resources refer to various online instruments, platforms, or materials that deliver information, services, or functionalities in an electronic format. For instance, in September 2024, BioLineRx Ltd., an Israel-based biopharmaceutical company, launched Mobilization Matters, a digital resource. Mobilization Matters is an interactive platform designed to educate healthcare professionals and patients about the mobilization of stem cells for transplantation. It offers comprehensive guidelines, best practices, and real-time tracking tools to optimize the stem cell collection process, thereby improving patient outcomes and ensuring efficient use of resources in transplantation procedures.
Hematopoietic Stem Cell Transplantation Market Leading Companies And Competitive Benchmarking
Major companies operating in the hematopoietic stem cell transplantation market are Pluristem Therapeutics Inc., Lonza Group AG, Escape Therapeutics Inc., Regen Biopharma Inc., Bluebird Bio Inc., CellGenix GmbH, CBR Systems Inc., Merck KGaA, Cord Blood Corporation, Kiadis Pharma NV, Marker Therapeutics Inc., Taiga Biotechnologies Inc., Takeda Pharmaceutical Company Limited, Talaris Therapeutics Inc., ViaCord LLC, ScienCell Research Laboratories Inc., BiolineRx, Stemcell Technologies Inc., ThermoGenesis Holdings Inc., MEDIPOST Co. Ltd., Anterogen. Co. Ltd., Pharmicell Inc., JCR Pharmaceuticals Co. Ltd., Holostem Terapie Avanzate Srl, Regrow Biosciences Pvt Ltd., Stempeutics Research Pvt Ltd.
View The Full Hematopoietic Stem Cell Transplantation Market Report:
Hematopoietic Stem Cell Transplantation Market Regional Analysis And Top Geography
North America was the largest region in the hematopoietic stem cell transplantation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global hematopoietic stem cell transplantation market during the forecast period. The regions covered in the hematopoietic stem cell transplantation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model









